Skip to main content
. 2016 Apr 27;8:203–216. doi: 10.1016/j.ebiom.2016.04.033

Fig. 2.

Fig. 2

Metabolite biomarkers associated to clinical variables. The relative abundance of C16 ceramide that is linked with innate immune activation marker %CD8 + HLA-DR + CD38 + T in each of the 4 group of individuals investigated is shown (P < 0.0239). Horizontal bars represent median. Inset represents the abundance of C16 ceramide versus %CD8 + HLA-DR + CD38 + T (Rho = 0.95).